Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
Long-term management of patients with Kawasaki disease should be tailored to the degree of coronary arterial involvement. This committee has made recommendations for each risk level about antiplatelet and anticoagulant therapy, physical activity, follow-up assessment by a pediatric cardiologist or primary care physician, and the appropriate diagnostic procedures that may be performed to evaluate cardiac disease. The risk level for a given patient with coronary arterial involvement may change over time because of changes in coronary artery morphology. The recommendations for management presented here are intended as practical interim guidelines until additional prospective or retrospective data are compiled to define more clearly the natural history of Kawasaki disease.
Dajani
A S
AS
Office of Scientific Affairs, American Heart Association, Dallas, TX 75231-4596.
Taubert
K A
KA
Takahashi
M
M
Bierman
F Z
FZ
Freed
M D
MD
Ferrieri
P
P
Gerber
M
M
Shulman
S T
ST
Karchmer
A W
AW
Wilson
W
W
D002309:Cardiology; D017023:Coronary Angiography; D004452:Echocardiography; D005080:Exercise Test; D006801:Humans; D009080:Mucocutaneous Lymph Node Syndrome / Q000175:diagnosis / Q000628:therapy*; D009204:Myocardial Revascularization; D012308:Risk Management; D012955:Societies, Medical; D015912:Thrombolytic Therapy; D013997:Time Factors